Lidocaine
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 137-58-6
Synonym(S): 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide, Lignocaine, Xylocaine
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 250 MG | 1366002-250-MG | In Stock | ₹ 40,756.13 |
1366002 - 250 MG
In Stock
Quantity
1
Base Price: ₹ 40,756.13
GST (18%): ₹ 7,336.103
Total Price: ₹ 48,092.233
grade
pharmaceutical primary standard
API family
lidocaine
manufacturer/tradename
USP
technique(s)
HPLC: suitablegas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
CCN(CC)CC(=O)Nc1c(C)cccc1C
InChI
1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)
InChI key
NNJVILVZKWQKPM-UHFFFAOYSA-N
Gene Information
human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Medchemexpress LLC HY-B0185 5g , Lidocaine CAS:137-58-6 Purity:>98% | -- | ₹ 6,167.70 | ||
Apexbio Technology LLC Lidocaine, 5g Cas# 137-58-6 | -- | ₹ 4,717.00 | ||
Sigma Aldrich Fine Chemicals Biosciences Lidocaine British Pharmacopoeia (BP) Reference Standard | 137-58-6 | MFCD00026733 | | -- | ₹ 28,455.97 | ||
Lidocaine Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 12,246.40 | ||
U.S. Pharmacopeia Lidocaine, 137-58-6, MFCD00026733, 250mg | -- | ₹ 30,854.52 | ||
Lidocaine | -- | ₹ 10,153.85 | ||
Lidocaine | -- | ₹ 14,732.83 | ||
Lidocaine | -- | ₹ 14,267.35 | ||
Lidocaine | -- | ₹ 4,275.88 | ||
137-58-6 | 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide | -- | ₹ 890.00 - ₹ 15,575.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Lidocaine USP reference standard for use in specified quality tests and assays.Also used to prepare standard and system suitability solution for assay, identification and impurity analysis according to given below monographs of the United States Pharmacopeia (USP):Lidocaine[1]Lidocaine Hydrochloride Topical Solution[2]Lidocaine Hydrochloride Oral Topical Solution[3]Lidocaine Hydrochloride Jelly[4]
- Biochem/physiol Actions: Na+ channel blocker; class IB antiarrhythmic that is rapidly absorbed after parenteral administration.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable